Lee's Pharm (00950) issued a total of 1,764,000 share purchase rights.
Lee's Big Pharma Company (00950) issues a statement that on October 15, 2025, in accordance with the regulations set forth on May 19, 2022...
LEE'S PHARM (00950) announced that on October 15, 2025, in accordance with the stock option plan adopted on May 19, 2022, it granted stock options (options) to several eligible participants (grantees), which can subscribe for a total of 1.764 million shares of the company's common stock.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
